This is a non-interventional study.
This is a non-interventional study. is an intervention with 13 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
No phase data available
Trial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
2
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Status
Recent Activity
Surviving the Pediatric Intensive Care Unit (PICU)
Translation, Cultural Adaptation and Validation of the Italian Version of Functional Rating Index in Patients With Chronic Low Back Pain
A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Singapore's Health Outcomes After Critical Illness in Kids
Exploring the Immunology of Sarcoidosis
Clinical Trials (13)
Surviving the Pediatric Intensive Care Unit (PICU)
Translation, Cultural Adaptation and Validation of the Italian Version of Functional Rating Index in Patients With Chronic Low Back Pain
A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Singapore's Health Outcomes After Critical Illness in Kids
Exploring the Immunology of Sarcoidosis
Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients
Development of the Work In Progress Questionnaire
Towards Better Preparedness for Future Catastrophes - Local Lessons-learned From COVID-19
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
Microvascular Dysfunction in Diabetic Peripheral Neuropathy
cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
LRRK2 G2385R Leucocyte and Urine Biomarker Study
Rivaroxaban ACS Specialist Cohort Event Monitoring Study
All 13 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 13